NASDAQ:PROF | Free Cash Flow | Profound Medical Corp.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.58M
2025-12-31-$6.57M
2025-03-31-$8.28M
2024-12-31-$5.88M
2024-03-31-$4.53M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$38.21M$176,000.00-$38.38M
2024-12-31-$23.45M
2023-12-31-$22.61M